The L.A. Times published an editorial July 29 summing up years of data showing that aggressively screening and treating people for cancer does not always benefit them. The editorial also points out that population based studies may not apply to people with known risk factors, like a family history of breast/ovarian cancer. The editorial also … Continued
According to a study of 186 women with ovarian cancer, women with high levels of emotional support lived longer than women without them. The study also suggests that a high degree of “instrumental support” – that is, tangible assistance – did not have any effect on survival. Read the abstract here
07/19/2012Research published July 16th in the Journal of Clinical Oncology shows that greater social attachment was associated with a lower likelihood of death for ovarian cancer patients. A group of researchers, including senior author and OCRF grantee Anil Sood, MD examined how social support related to long term survival. Two types of social support were … Continued
07/18/2012 A study published in Cancer Epidemiology, Biomarkers, and Prevention this month re-confirms that there is no link between use of fertility drugs and an elevated risk of ovarian cancer. While in the past studies on this subject have produced conflicting results, this study adds to the increasing body of work showing that use of … Continued
A study of 219 ovarian cancer survivors showed that those who did “regular exercise and yoga had higher scores in physical functioning, fewer limitations with physical and emotional health, less pain, and more vitality than survivors who reported participating in regular exercise only.” Read the full abstract here
06/25/2012 Writing in the Journal of Clinical Oncology, Australian researchers suggest because BRCA mutation status impacts survival and treatment response, all women with nonmucinous ovarian cancer, regardless of family history, should be offered BRCA1/2 mutation testing. Researchers from the Peter MacCallum Cancer Centre in East Melbourne, Australia, screened 1,001 women with ovarian cancer to investigate … Continued
A new study of 1,001 women with ovarian cancer found that 14% of them carried a BRCA1 or BRCA2 mutation. However, 44% of those women did not have a family history of breast or ovarian cancer. The BRCA mutations can not only help evaluate risk of developing ovarian cancer, but may direct treatment and can … Continued
A new article explores the long term effects of cancer care, and the unique needs of survivors. With 18 million cancer survivors expected to be alive in the United States by 2022, this follow up care is important. It may require more education of a primary care provider and/or coordination between the oncologist and primary … Continued
05/29/2012 In an abstract that will be presented at the American Society of Clinical Oncology annual meeting in Chicago this weekend, researchers report that in patients with platinum-sensitive recurrent serous ovarian cancer, olaparib plus paclitaxel plus carboplatin, followed by maintenance treatment with olaparib, resulted in a significant improvement in progression-free survival compared with paclitaxel plus … Continued
05/29/2012 Research that will be presented at the 2012 American Society of Clinical Oncology meeting June 1-5th suggests that obesity did not affect recurrence, time to recurrence, or progression-free survival in women with epithelial ovarian cancer following surgery and chemotherapy. Previous research examining the relationship between obesity and ovarian cancer has yielded mixed results. Click … Continued
Based on data showing that removing a woman’s fallopian tubes removes her risk of developing ovarian cancer, doctors are now urging women who are having their tubes tied to have them removed, instead. There is an increasing body of evidence suggesting that ovarian cancer may start in the fallopian tubes. Surgery to remove the fallopian … Continued
04/30/2012 Research published this month in the Journal of the National Cancer Institute suggests that DNA repair genes may be a predictor of ovarian cancer survival. Researchers at Dana-Farber Cancer Institute in Boston used gene expression data from The Cancer Genome Atlas database to develop a molecular “score” by looking at genes involved in … Continued
Get email updates about research news, action alerts, and ways to join the fight.
